• Mashup Score: 3

    The barrier function of the glycosaminoglycan (GAG) layer of the urothelium was identified by Parsons in 1975, and intravesical therapies to treat chronic inflammatory conditions of the bladder were developed soon after. However, the active role of the urothelium in normal physiology and in the genesis of lower urinary tract dysfunction has become apparent only in recent years [1]. The…

    Tweet Tweets with this article
    • Intravesical GAG replacement therapies for #bladder pain syndrome / interstitial #cystitis - @jkhastgir provides an update https://t.co/F8vkH1404F

  • Mashup Score: 0

    The barrier function of the glycosaminoglycan (GAG) layer of the urothelium was identified by Parsons in 1975, and intravesical therapies to treat chronic inflammatory conditions of the bladder were developed soon after. However, the active role of the urothelium in normal physiology and in the genesis of lower urinary tract dysfunction has become apparent only in recent years [1]. The…

    Tweet Tweets with this article
    • Intravesical GAG replacement therapies for #bladder pain syndrome / interstitial #cystitis – @jkhastgir provides an update https://t.co/Yu8AaDaOXC

  • Mashup Score: 0

    Many interesting studies on urological infection have been published in the past year including nonantibiotic therapy for acute cystitis, the utility of the Acute Cystitis Symptom Score, specific identification of health-care-associated urinary tract infection and a multidisciplinary approach to prostatitis.

    Tweet Tweets with this article
    • FEBRUARY ISSUE | Year in Review: INFECTION — key advances in urological infection & inflammation in 2019: nonantibiotic therapy for #cystitis, identifying health-care-associated urinary tract infections and a multidisciplinary approach to #prostatitis -> https://t.co/sOuPizWcSi https://t.co/SAjYsOfrtj